Optimize Efficiency and Outcomes with Data-driven Infectious Disease Management
BIOMÉRIEUX AGILIST™ is a secure, cloud-based clinical informatics software-as-a-service that connects and integrates disparate data into a single management application. BIOMÉRIEUX AGILIST™ gives you a holistic view of relevant lab and clinical data across departments, processes, and vendors and translates this data into actionable insights visualized on easy-to-use dashboards.
Utilization of our intuitive AGILIST™ platform provides the capability to track and improve metrics that can impact patient care and outcomes. We leverage our expertise in microbiology and infectious diseases to help health systems understand their current processes then visualize and analyze their data.
BIOMÉRIEUX AGILIST™ Addresses Key Issues Healthcare Organizations Face in Infectious Disease Management:
My patient is 92 years old, why is her suggested empiric therapy based on a data set for everyone who came to the hospital last year?
Generating the antibiogram is time consuming with data coming from multiple sources. For this reason, it is often a snapshot based on last year’s data and is quickly out of date. Data is pooled and becomes an average of all patients rather than tailored to any one patient. Critical drug choices are made using this method that does not consider specific patient factors.
What if you could harness the power of an advanced analytic platform to drill down to an antibiogram that is more suited to each patient? What if physicians could decide to prioritize therapies according to toxicity, convenience to the patient, or a number of other patient-specific factors?
Discover AGILIST Stewardship
How do I drive handshake stewardship with physicians to effectively communicate the optimal drug duration?
Biomarkers can play an important role in understanding your patients' disposition and help with clinical treatment decisions. However, understanding how diagnostic tests, especially those concerning biomarkers like VIDAS® B·R·A·H·M·S PCT™, are used is difficult in many institutions. This makes having clinical conversations around test utilization and the impact on patient outcomes nearly impossible. The stewardship team often does not know who is using biomarkers and on which patients, and the lab is blind to the impact of high medical value biomarkers on patient outcomes.
What if you could understand exactly how biomarkers are being used? What if you knew who was ordering a test and making clinical decisions based on the result? What if you could then understand the impact on patient outcomes in your institution? What if you could have real conversations based on objective clinical data and its impact on patient care?
Discover AGILIST Value
How do I deliver accurate lab results faster to support my hospital’s Antimicrobial Stewardship Team?
Microbiology labs provide nearly all the objective data that is used in infectious disease clinical decision making. The process of producing results usually relies on traditional workflows. When this process is combined with the longer incubation times required by traditional methodologies, results can take hours or even days longer to reach clinicians, which delays crucial treatment decisions.
What if you could work with a team of experts and an analytic platform to visualize and understand the workflow data from your lab? What if you could optimize the use of people, processes, and technology to deliver clinically relevant information to clinicians hours and sometimes even days earlier?
Discover AGILIST Complete
AGILIST Value: VIDAS® B•R•A•H•M•S PCT™ | Measure Impact on Outcomes
A deep look at the utilization of VIDAS® B·R·A·H·M·S PCT™, tied to antibiotic usage and patient outcomes that integrates additional data from the laboratory, Pharmacy, Admit, Discharge, Transfer (ADT) system, and Electronic Health Records (EHR). This module aims to optimize biomarker utilization, view clinician prescribing, and response.
Benchmark and monitor best practices
Facilitate informed clinical discussions and targeted education
Quantify how diagnostic stewardship drives value-based healthcare
- PCT Usage by Indication
- Clinician-specific Utilization and Outcomes Measures
- Outcomes Analyses (e.g., Length of Stay)
- Pharmaceutical Utilization Dashboards: Days of Therapy, Length of Therapy Analysis
- Mortality Analysis
- Clinician-specific Results Response
bioMérieux takes the security of your data and patient health information extremely seriously. For this reason we have carefully chosen technology partners that have a long track record of data security and are approved for use with patient data.
Our Integration Engine is an FDA Certified non-device MDDS (under the 21st Century Cures Act) and compliant to FDA 21 CFR Part 820.
BIOMÉRIEUX AGILIST™ is hosted on a secure private cloud that is compliant to HIPAA and GxP (FDA 21 CFR Part11). As a secure, cloud-based service, AGILIST is designed to comply with the HIPAA Privacy Rules, Safe Harbor method for de-identification of data:
- De-Identify Data – takes place in the Integration Engine inside your firewall.
- Securely Transmit Data – with different encryption methods and a complete audit trail of all data transfers, you have options on how we securely transfer files to the AGILIST environment. No PHI is transferred outside your firewall
- Offer Secure Private Cloud Hosting – our secure cloud is compliant to HIPAA and GxP (FDA 21 CFR Part11).
- Deliver Secure User And Administrator Access – authentication and identification also integrates with local administrator’s identity management or Active Directory systems
You can only see your own data, which is stored on a private cloud.
Interested in BIOMÉRIEUX AGILIST™?
Fill out the form below to be contacted by a bioMérieux representative, who will provide you with more information on how we can support your evidence-based decision making with BIOMÉRIEUX AGILIST™!